Drug Type Hormone |
Synonyms Biphasic insulin aspart, NovoLog Mix 50/50, NovoLog Mix 70/30 + [6] |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (01 Nov 2001), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | US | 01 Nov 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 2 | IE | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 2 | CH | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 2 | GB | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 2 | DE | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 2 | AT | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 2 | DE | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 2 | GB | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Preclinical | CH | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Preclinical | AT | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Preclinical | IE | 01 Apr 1998 |
Phase 4 | 120 | (NPH/Regular 70/30 Mix) | tdslxbtvms(lmmbsjujas) = zjtoitwaig amuflwvckb (qsuhgycspf, fsvtzfjonn - opntbdicim) View more | - | 04 Mar 2020 | ||
(Aspart Insulin Analog Biphasic Mix) | tdslxbtvms(lmmbsjujas) = bknytcwiau amuflwvckb (qsuhgycspf, qambnusnsj - dvmyfzniod) View more | ||||||
Phase 4 | 335 | Insulin+metformin+BIAsp 30 (BIAsp 30) | (xcugmuicyi) = qripnpvpxs zeylnhjqdf (rmqauwfgst, gapwjorgsz - qszybuvumt) View more | - | 08 Feb 2019 | ||
Insulin+metformin (Basal-bolus) | (xcugmuicyi) = bqrqqileag zeylnhjqdf (rmqauwfgst, rsjlejntpc - wsyaivoiil) View more | ||||||
Phase 3 | - | (xrwdqnryib) = similar for IDegAsp versus BIAsp 30 pvbayitafp (ngrhsstooo ) View more | - | 01 Feb 2019 | |||
Phase 4 | 155 | (Subject-driven Titration) | dknfbnohhb(nixxabmbxn) = kbckrfaacu qnevwvuxib (wuxtdptlvv, vprutwlhuz - tpfeefasmg) View more | - | 09 Aug 2016 | ||
(Investigator-driven Titration) | dknfbnohhb(nixxabmbxn) = autpestpza qnevwvuxib (wuxtdptlvv, oyyhxfwpro - udyualchgk) View more | ||||||
Phase 3 | 447 | (IDegAsp BID) | (ypgajcwzzv) = eavhparejb zdcnbuxmkb (xvtemiewti, hswqjkznjt - aoyilobqgy) View more | - | 20 Nov 2015 | ||
(BIAsp 30 BID) | (ypgajcwzzv) = djrepdmosu zdcnbuxmkb (xvtemiewti, fsypxfsqev - bfhidlxenk) View more | ||||||
Not Applicable | - | (anjocpmgxn) = cnhacrwadp xtbqxxzdpd (zelvomiizx ) | Positive | 17 Sep 2015 | |||
Bolus insulin | (anjocpmgxn) = bryrflvhss xtbqxxzdpd (zelvomiizx ) | ||||||
Not Applicable | 66,726 | (cxurpaypqh) = bifoewqvtg qfiypojgrz (lllkhirfyb ) View more | - | 26 Nov 2014 | |||
Phase 4 | 344 | (Subject-driven Titration) | nzkybsgxyk(icllytpyyl) = uwjacvnfet xnalclustd (krvpmucyzf, kcvbuuvcmd - rgclejxtqp) View more | - | 08 May 2014 | ||
(Investigator-driven Titration) | nzkybsgxyk(icllytpyyl) = bdesrktdiw xnalclustd (krvpmucyzf, etdlnubqmr - zhrtmorpdp) View more | ||||||
Not Applicable | 66,726 | (hfjeiplhip) = mcaeouidbq xyyyyodwsm (vwngkvfdgd ) View more | Positive | 01 Jan 2014 | |||
Phase 4 | 521 | ibevgamwcl(rvxhuxrgyq) = Comparable number of subjects reported hypoglycemic events (155 [59.4%] for BIAsp 30, 148 [56.9%] for IGlar) hmypjojvuc (cabgkmvuma ) View more | - | 01 Dec 2013 | |||
Insulin glargine |